Morgan Stanley’s Tenax Therapeutics TENX Stock Holding History

Morgan Stanley’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.54M	Buy	596,564 +188	+0%	+$2.54K	﹤0.01%	3600
2025 Q4	$7.27M	Buy	596,376 +418,047	+234%	+$3.64M	﹤0.01%	3890
2025 Q3	$1.36M	Buy	178,329 +319	+0.2%	+$1.95K	﹤0.01%	5004
2025 Q2	$1.03M	Buy	178,010 +56,916	+47%	+$329K	﹤0.01%	5088
2025 Q1	$793K	Buy	121,094 +46,649	+63%	+$299K	﹤0.01%	5115
2024 Q4	$461K	Buy	74,445 +74,185	+28,533%	+$360K	﹤0.01%	5445
2024 Q3	$900	Hold	260	–	–	﹤0.01%	7233
2024 Q2	$784	Hold	260	–	–	﹤0.01%	7182
2024 Q1	$1.1K	Sell	260 -257	-50%	-$1.97K	﹤0.01%	7162
2023 Q4	$11.4K	Buy	517 +509	+6,363%	+$12.2K	﹤0.01%	6806
2023 Q3	$202	Sell	8 -1	-11%	-$25	﹤0.01%	7386
2023 Q2	$205	Hold	9	–	–	﹤0.01%	7452
2023 Q1	$316	Hold	9	–	–	﹤0.01%	7484
2022 Q4	$1.51K	Hold	9	–	–	﹤0.01%	7413
2022 Q3	$2K	Buy	+9	New	+$3.61K	﹤0.01%	7490
2022 Q2	–	Hold	0	–	–	–	7969
2022 Q1	–	Hold	0	–	–	–	8116
2021 Q4	–	Hold	0	–	–	–	8106
2021 Q3	–	Sell	-24	Closed	-$62.8K	–	8022
2021 Q2	$80K	Buy	+24	New	+$76.1K	﹤0.01%	6448
2021 Q1	–	Hold	0	–	–	–	7563
2020 Q4	–	Hold	0	–	–	–	7110
2020 Q3	–	Hold	0	–	–	–	6825
2020 Q2	–	Hold	0	–	–	–	6720
2020 Q1	–	Hold	0	–	–	–	6703
2019 Q4	–	Hold	0	–	–	–	6760
2019 Q3	–	Hold	0	–	–	–	6755
2019 Q2	–	Hold	0	–	–	–	6746
2019 Q1	–	Hold	0	–	–	–	6704
2018 Q4	–	Hold	0	–	–	–	6734
2018 Q3	–	Hold	0	–	–	–	6806
2018 Q2	–	Hold	0	–	–	–	6752
2018 Q1	–	Hold	0	–	–	–	6698
2017 Q4	–	Hold	0	–	–	–	6508
2017 Q3	–	Hold	0	–	–	–	6409
2017 Q2	–	Hold	0	–	–	–	6466
2017 Q1	–	Hold	0	–	–	–	6508
2016 Q4	–	Hold	0	–	–	–	6159
2016 Q3	–	Hold	0	–	–	–	6240
2016 Q2	–	Hold	0	–	–	–	6189
2016 Q1	–	Hold	0	–	–	–	6326
2015 Q4	–	Hold	0	–	–	–	6348
2015 Q3	–	Hold	0	–	–	–	6179
2015 Q2	–	Hold	0	–	–	–	6244
2015 Q1	–	Sell	-1	Closed	-$105K	–	6100
2014 Q4	$180K	Sell	1 -1	-50%	-$121K	﹤0.01%	5297
2014 Q3	$244K	Buy	+2	New	+$257K	﹤0.01%	5032
2014 Q2	–	Sell	-1	Closed	-$154K	–	5798
2014 Q1	$234K	Buy	+1	New	+$198K	﹤0.01%	5041
2013 Q4	–	Hold	0	–	–	–	5638

Other funds holding TENX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Morgan Stanley's TENX Position: Q1 2026 in Review

Morgan Stanley increased its Tenax Therapeutics (TENX) stake by 0.03% in Q1 2026, buying an estimated $2.54K and bringing the position to 596,564 shares worth $9.54M. The position accounts for ﹤0.01% of the portfolio, ranked #3600.

Morgan Stanley first reported a position in TENX in Q1 2014 and has held it in 19 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

Morgan Stanley held 596,564 shares of Tenax Therapeutics worth $9.54M as of Q1 2026.
Morgan Stanley bought 188 Tenax Therapeutics shares in Q1 2026, an estimated $2.54K.
Tenax Therapeutics made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #3600 holding.
Morgan Stanley first reported a position in Tenax Therapeutics in Q1 2014 and has held it in 19 quarters since.
80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.